483
Lonza Biologics, Inc.Lonza Biologics, Inc. – FDA 483, Mar 7, 2024
Record Details
An FDA inspection of Lonza Biologics, Inc. in Portsmouth, NH, a biological drug substance manufacturer, revealed two significant observations. The firm failed to adequately investigate unexplained discrepancies related to calibration data and incorrectly assessed failing data as passing. Additionally, the company did not follow its own established procedures for process descriptions, continuing manufacturing even after critical test failures were identified for bulk drug substances.
View Company Profile
ID · a5417b6a-1ebe-4cd5-8ba7-eae412f0931f
Other documents for Lonza Biologics, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.